JPMorgan Healthcare Leaders ETFJDOC
Type
ETF
Peer group
Global equity
Net assets
$11.1M
Expense ratio
0.65%
1-year return
+22.8%
3 years, a year
—
5 years, a year
—
12-month yield
0.84%
Holdings
66
What it aims to do.
The Fund seeks to provide long-term capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| LLY Eli Lilly & Co. | 6.81% |
| ABBV AbbVie, Inc. | 6.58% |
| JNJ Johnson & Johnson | 6.20% |
| UNH UnitedHealth Group, Inc. | 5.83% |
| AstraZeneca plc | 4.57% |
| MRK Merck & Co., Inc. | 4.21% |
| BMY Bristol-Myers Squibb Co. | 3.50% |
| TMO Thermo Fisher Scientific, Inc. | 3.19% |
| ISRG Intuitive Surgical, Inc. | 2.96% |
| CVS CVS Health Corp. | 2.71% |
More on JDOC.
- JDOC overview
- JDOC holdings
- JDOC risk
- JDOC costs
- JDOC money in and out
- JDOC share classes
- Compare JDOC with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.